Evidence map›Paper›PMID 37919479›Full record

ReviewLasers in medical science2023

Photodynamic therapy in cancer stem cells - state of the art.

Ana Melissa C Ibarra, Emilia Maria G Aguiar, Cássia B R Ferreira, Juliana M Siqueira, Luciana Corrêa, Fabio D Nunes, Adriana Lino-Dos-Santos Franco, Rebeca B Cecatto, Michael R Hamblin, Maria Fernanda S D Rodrigues

Abstract readReview
PubMed Publisher
In one paragraph

Review in Lasers in medical science, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Review
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Ana Melissa C IbarraPostgraduate Program in Biophotonics Applied to Health Sciences, Nove de Julho University - UNINOVE, São Paulo, Brazil.
Emilia Maria G AguiarSchool of Dentistry, University of São Paulo - FOUSP, São Paulo, Brazil.
Cássia B R FerreiraPostgraduate Program in Biophotonics Applied to Health Sciences, Nove de Julho University - UNINOVE, São Paulo, Brazil.
Juliana M SiqueiraSchool of Dentistry, University of São Paulo - FOUSP, São Paulo, Brazil.
Luciana CorrêaSchool of Dentistry, University of São Paulo - FOUSP, São Paulo, Brazil.
Fabio D NunesSchool of Dentistry, University of São Paulo - FOUSP, São Paulo, Brazil.
Adriana Lino-Dos-Santos FrancoPostgraduate Program in Biophotonics Applied to Health Sciences, Nove de Julho University - UNINOVE, São Paulo, Brazil.
Rebeca B CecattoPostgraduate Program in Biophotonics Applied to Health Sciences, Nove de Julho University - UNINOVE, São Paulo, Brazil.
Michael R HamblinLaser Research Centre, Faculty of Health Science, University of Johannesburg, Johannesburg, South Africa.
Maria Fernanda S D RodriguesPostgraduate Program in Biophotonics Applied to Health Sciences, Nove de Julho University - UNINOVE, São Paulo, Brazil. fernandadestrorodrigues@gmail.com.
Universidade Nove de Julho · BRUniversidade de São Paulo · BRUniversity of Johannesburg · ZA

Funding

Coordenação de Aperfeiçoamento de Pessoal de Nível Superior 88882.365373/2019-01Fundação de Amparo à Pesquisa do Estado de São Paulo 2018/08540-8Fundação de Amparo à Pesquisa do Estado de São Paulo 2019/09465National Institute of Health R01AI050875National Institute of Health R21AI121700
6 · The paper itself

Abstract

Despite significant efforts to control cancer progression and to improve oncology treatment outcomes, recurrence and tumor resistance are frequently observed in cancer patients. These problems are partly related to the presence of cancer stem cells (CSCs). Photodynamic therapy (PDT) has been developed as a therapeutic approach for solid tumors; however, it remains unclear how this therapy can affect CSCs. In this review, we focus on the effects of PDT on CSCs and the possible changes in the CSC population after PDT exposure. Tumor response to PDT varies according to the photosensitizer and light parameters employed, but most studies have reported the successful elimination of CSCs after PDT. However, some studies have reported that CSCs were more resistant to PDT than non-CSCs due to the increased efflux of photosensitizer molecules and the action of autophagy. Additionally, using different PDT approaches to target the CSCs resulted in increased sensitivity, reduction of sphere formation, invasiveness, stem cell phenotype, and improved response to chemotherapy. Lastly, although mainly limited to in vitro studies, PDT, combined with targeted therapies and/or chemotherapy, could successfully target CSCs in different solid tumors and promote the reduction of stemness, suggesting a promising therapeutic approach requiring evaluation in robust pre-clinical studies.

Indexed as

NeoplasmsPhotochemotherapyHumansNeoplastic Stem CellsPhotosensitizing AgentsPhotosensitizing AgentsCancer stem cellsPhotodynamic therapySolid tumorsTherapy resistanceTumor-initiating cells

Identifiers

PMID37919479
OpenAlexW4388248446

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.